• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型喹诺酮类药物氟罗沙星(RO 23 - 6240)的体外活性比较

Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240).

作者信息

Verschraegen G, Claeys G, Van den Abeele A M

机构信息

Department of Medical Microbiology, State University of Ghent, University Hospital, Belgium.

出版信息

Eur J Clin Microbiol Infect Dis. 1988 Feb;7(1):63-6. doi: 10.1007/BF01962177.

DOI:10.1007/BF01962177
PMID:3132381
Abstract

RO 23-6240 (fleroxacin), pefloxacin, augmentin, cefaclor, cef-uroxime, ceftazidime, vancomycin, piperacillin and amikacin were tested against a wide variety of gram-positive and gram-negative bacteria. The MICs of fleroxacin were very similar to those of pefloxacin. Against all the bacterial groups tested, the quinolones compared favorably with the other antimicrobials tested, particularly against the more resistant species such as Corynebacterium group JK and D2 and methicillin-resistant staphylococci.

摘要

对氟罗沙星(RO 23 - 6240)、培氟沙星、阿莫西林克拉维酸钾、头孢克洛、头孢呋辛、头孢他啶、万古霉素、哌拉西林和丁胺卡那霉素针对多种革兰氏阳性菌和革兰氏阴性菌进行了测试。氟罗沙星的最低抑菌浓度(MIC)与培氟沙星的非常相似。在所有测试的细菌组中,喹诺酮类药物与其他测试抗菌药物相比表现良好,尤其是对耐药性更强的菌种,如JK组和D2组棒状杆菌以及耐甲氧西林葡萄球菌。

相似文献

1
Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240).新型喹诺酮类药物氟罗沙星(RO 23 - 6240)的体外活性比较
Eur J Clin Microbiol Infect Dis. 1988 Feb;7(1):63-6. doi: 10.1007/BF01962177.
2
In vitro activity of the new 4-quinolone compound Ro 23-6240.新型4-喹诺酮化合物Ro 23-6240的体外活性
Eur J Clin Microbiol. 1987 Apr;6(2):161-4. doi: 10.1007/BF02018199.
3
Comparative in vitro activity of RO 23-6240 (fleroxacin), a new 4-quinolone derivative.新型4-喹诺酮衍生物RO 23-6240(氟罗沙星)的体外活性比较
Eur J Clin Microbiol. 1987 Aug;6(4):482-5. doi: 10.1007/BF02013116.
4
In vitro activity of RO 23-6240 (AM-833): a new fluoroquinolone.新型氟喹诺酮RO 23-6240(AM-833)的体外活性
Diagn Microbiol Infect Dis. 1987 Apr;6(4):293-9. doi: 10.1016/0732-8893(87)90178-7.
5
In vitro activity of fleroxacin against aerobic gram-positive bacteria including Corynebacterium jeikeium.氟罗沙星对包括杰氏棒状杆菌在内的需氧革兰氏阳性菌的体外活性。
Chemotherapy. 1990;36(6):403-6. doi: 10.1159/000238796.
6
The comparative in-vitro activity of pefloxacin.培氟沙星的体外比较活性。
J Antimicrob Chemother. 1986 Apr;17 Suppl B:1-10. doi: 10.1093/jac/17.suppl_b.1.
7
In vitro activity of pefloxacin against gram-negative and gram-positive bacteria in comparison with other antibiotics.培氟沙星与其他抗生素相比,对革兰氏阴性菌和革兰氏阳性菌的体外活性。
Chemioterapia. 1987 Oct;6(5):319-23.
8
[Development of resistance in bacteria interacting with subinhibitory antibiotic concentrations].[与亚抑菌浓度抗生素相互作用的细菌耐药性的发展]
Mikrobiyol Bul. 1992 Oct;26(4):333-7.
9
Comparative in-vitro activity of Ro 23-6240, a new trifluorinated quinolone.
J Antimicrob Chemother. 1987 Sep;20(3):363-72. doi: 10.1093/jac/20.3.363.
10
In-vitro activity of fleroxacin compared with three other quinolones.氟罗沙星与其他三种喹诺酮类药物的体外活性比较。
J Antimicrob Chemother. 1988 Oct;22 Suppl D:19-23. doi: 10.1093/jac/22.supplement_d.19.

引用本文的文献

1
Fluoroquinolone antimicrobial agents.氟喹诺酮类抗菌剂。
Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.
2
Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.培氟沙星。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1989 May;37(5):628-68. doi: 10.2165/00003495-198937050-00003.
3
Developments in quinolones. Bacteriology, pharmacokinetics and initial clinical experience of several investigational quinolone derivatives.喹诺酮类药物的进展。几种研究中的喹诺酮衍生物的细菌学、药代动力学及初步临床经验。

本文引用的文献

1
The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid.环丙沙星与诺氟沙星和萘啶酸的体外活性比较。
J Antimicrob Chemother. 1984 Apr;13(4):325-31. doi: 10.1093/jac/13.4.325.
2
In vitro activity of the new 4-quinolone compound Ro 23-6240.新型4-喹诺酮化合物Ro 23-6240的体外活性
Eur J Clin Microbiol. 1987 Apr;6(2):161-4. doi: 10.1007/BF02018199.
3
Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone.新型三氟喹诺酮Ro 23-6240的药代动力学和组织穿透性
Pharm Weekbl Sci. 1989 Apr 28;11(2):33-43. doi: 10.1007/BF01962973.
4
In vitro activity of 79 antimicrobial agents against Corynebacterium group D2.79种抗菌剂对D2群棒状杆菌的体外活性
Antimicrob Agents Chemother. 1991 Oct;35(10):2140-3. doi: 10.1128/AAC.35.10.2140.
5
Cross-resistance and cross-susceptibility between fluoroquinolone agents.氟喹诺酮类药物之间的交叉耐药性和交叉敏感性。
Eur J Clin Microbiol Infect Dis. 1991 Dec;10(12):1013-8. doi: 10.1007/BF01984922.
6
Fleroxacin clinical pharmacokinetics.氟罗沙星的临床药代动力学。
Clin Pharmacokinet. 1992 Feb;22(2):116-31. doi: 10.2165/00003088-199222020-00003.
Antimicrob Agents Chemother. 1987 Feb;31(2):161-3. doi: 10.1128/AAC.31.2.161.
4
Activity of ciprofloxacin against multiply resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, and group JK corynebacteria.环丙沙星对多重耐药铜绿假单胞菌、表皮葡萄球菌和JK组棒状杆菌的活性。
Antimicrob Agents Chemother. 1986 Dec;30(6):940-1. doi: 10.1128/AAC.30.6.940.
5
In-vitro activity of pefloxacin against micro-organisms multiply resistant to beta-lactam antibiotics and aminoglycosides.
J Antimicrob Chemother. 1986 Apr;17 Suppl B:11-7. doi: 10.1093/jac/17.suppl_b.11.
6
In vitro activity of Ro 23-6240, a new fluorinated 4-quinolone.新型氟化4-喹诺酮Ro 23-6240的体外活性
Antimicrob Agents Chemother. 1986 Apr;29(4):675-80. doi: 10.1128/AAC.29.4.675.
7
The comparative in-vitro activity of pefloxacin.培氟沙星的体外比较活性。
J Antimicrob Chemother. 1986 Apr;17 Suppl B:1-10. doi: 10.1093/jac/17.suppl_b.1.